Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ferris

Showing results (521-530 of 818) with videos related to

Pageof 82
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2012
Prospective evaluation of patient-reported quality-of-life outcomes following SBRT ± cetuximab for locally-recurrent, previously-irradiated head and neck cancerJohn A Vargo, Dwight E Heron, Robert L Ferris, et al.
Cancer Research|December 3, 2005
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neckAndreas Albers, Koji Abe, Jennifer Hunt, et al.
Head & Neck|March 15, 2018
Cost-effectiveness analysis of salvage therapies in locoregional previously irradiated head and neck cancerHaYeon Kim, John A Vargo, Sushil Beriwal, et al.
Ophthalmology|September 19, 2015
Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT)Gui-shuang Ying, Maureen G Maguire, Ebenezer Daniel, et al.
Human Genetics|August 11, 2014
Predicting survival in head and neck squamous cell carcinoma from TP53 mutationDavid L Masica, Shuli Li, Christopher Douville, et al.
Oncoimmunology|August 17, 2017
Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanomaMasahiro Kikuchi, David A Clump, Raghvendra M Srivastava, et al.
BMC Cancer|November 8, 2015
MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancerBhavana V Chapman, Abigail I Wald, Parvez Akhtar, et al.
Proteomics. Clinical Applications|February 24, 2009
Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseasesFaina Linkov, Robert L Ferris, Zoya Yurkovetsky, et al.
Ophthalmology|May 10, 2016
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials, Maureen G Maguire, Daniel F Martin, et al.
Head & Neck|July 8, 2021
The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivorsKhalil Baddour, Mark Fadel, Meng Zhao, et al.
Pageof 82

Showing results (521-530 of 818) with videos related to

Sort By:
Pageof 82
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2012
Prospective evaluation of patient-reported quality-of-life outcomes following SBRT ± cetuximab for locally-recurrent, previously-irradiated head and neck cancerJohn A Vargo, Dwight E Heron, Robert L Ferris, et al.
Cancer Research|December 3, 2005
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neckAndreas Albers, Koji Abe, Jennifer Hunt, et al.
Head & Neck|March 15, 2018
Cost-effectiveness analysis of salvage therapies in locoregional previously irradiated head and neck cancerHaYeon Kim, John A Vargo, Sushil Beriwal, et al.
Ophthalmology|September 19, 2015
Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT)Gui-shuang Ying, Maureen G Maguire, Ebenezer Daniel, et al.
Human Genetics|August 11, 2014
Predicting survival in head and neck squamous cell carcinoma from TP53 mutationDavid L Masica, Shuli Li, Christopher Douville, et al.
Oncoimmunology|August 17, 2017
Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanomaMasahiro Kikuchi, David A Clump, Raghvendra M Srivastava, et al.
BMC Cancer|November 8, 2015
MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancerBhavana V Chapman, Abigail I Wald, Parvez Akhtar, et al.
Proteomics. Clinical Applications|February 24, 2009
Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseasesFaina Linkov, Robert L Ferris, Zoya Yurkovetsky, et al.
Ophthalmology|May 10, 2016
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials, Maureen G Maguire, Daniel F Martin, et al.
Head & Neck|July 8, 2021
The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivorsKhalil Baddour, Mark Fadel, Meng Zhao, et al.
Pageof 82